Asia
Giant Biogene Unit Gets Registration Certificate for Neck Wrinkle Injection
Giant Biogene (HKG:2367) unit Shaanxi Giant Biotechnology obtained a medical device registration certificate for its cross-linked recombinant collagen implant from China's National Medical Products Administration.The drug is intended for intradermal injection into the dermis layer of the neck to correct moderate to severe horizontal neck wrinkles, according to a Wednesday Hong Kong bourse filing.
HKG:2367
